Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
11.97
-0.37 (-3.00%)
At close: Aug 12, 2026, 4:00 PM EDT
12.03
+0.06 (0.50%)
After-hours: Aug 12, 2026, 7:34 PM EDT
TNXP Market Cap
TNXP has a market cap or net worth of $205.3 million as of August 12, 2026. Its market cap has decreased by -47.92% in one year.
Market Cap
205.30M
Enterprise Value
30.34M
1-Year Change
-47.92%
Ranking
Category
Stock Price
$11.97
ChartMarket Cap Chart
Since July 16, 2019, TNXP's market cap has increased from $7.29M to $205.30M, an increase of 2,714.74%. That is a compound annual growth rate of 60.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 205.30M | 6.07% |
| Dec 31, 2025 | 193.56M | 214.02% |
| Dec 31, 2024 | 61.64M | 160.94% |
| Dec 29, 2023 | 23.62M | 5.35% |
| Dec 30, 2022 | 22.42M | -87.36% |
| Dec 31, 2021 | 177.42M | 37.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alpha Cognition | 198.80M |
| Alector | 198.75M |
| Protalix BioTherapeutics | 198.21M |
| PepGen | 197.13M |
| Corbus Pharmaceuticals Holdings | 196.70M |
| Coherus Oncology | 196.22M |
| Korro Bio | 195.11M |
| Immunic | 194.79M |